Erythromycin lactobionate 500 MG Injection [Erythrocin] — RxCUI 1668267
RxNorm drug concept · Semantic branded drug
RxCUI 1668267
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1668267
Official nameErythromycin lactobionate 500 MG Injection [Erythrocin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asErythrocin 500 MG Injection; Erythrocin Lactobionate 500 MG Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)23 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Erythromycin Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's used to treat bacterial infections on the surface of your eye — the conjunctiva (the clear membrane over the white part) and the cornea (the clear front surface). It's also us...
- What exactly does this eye ointment treat?
- Gently pull your lower eyelid down to create a small pocket, then squeeze a ribbon of ointment — about 1 cm, roughly the size of a grain of rice — into that pocket. Blink a few tim...
- How do I apply the ointment without making a mess?
🕸️ Concept Web — How Erythromycin lactobionate 500 MG Injection [Eryt... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Erythromycin lactobionate 500 MG Injection [Erythrocin]
RxCUI 1668267 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Erythromycin
4053IN -
Erythromycin lactobionate
24347PIN
-
Erythromycin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Erythrocin
645943BN
-
Erythrocin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Erythromycin Injection
1668263SCDF -
Erythromycin lactobionate Injection
2647233SCDFP -
Erythromycin Injectable Product
1164500SCDG -
Erythromycin lactobionate Injectable Product
2661689SCDGP -
Erythromycin Injection [Erythrocin]
1720315SBDF -
Erythromycin lactobionate Injection [Erythrocin]
2656070SBDFP -
Erythrocin Injectable Product
1720316SBDG -
Injection
1649574DF - +1 more in this family
-
Erythromycin Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Erythromycin lactobionate 500 MG Injection
1668264SCD -
Erythromycin lactobionate 500 MG
1668262SCDC -
Erythromycin lactobionate 500 MG [Erythrocin]
1720314SBDC
-
Erythromycin lactobionate 500 MG Injection
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Erythromycin lactobionate 500 MG Injection
SCD · 1668264 -
Erythromycin lactobionate 500 MG
SCDC · 1668262 -
Erythromycin Injection
SCDF · 1668263 -
Erythromycin lactobionate Injection
SCDFP · 2647233 -
Erythromycin Injectable Product
SCDG · 1164500 -
Erythromycin lactobionate Injectable Product
SCDGP · 2661689
Brand-Name Concepts
-
Erythromycin lactobionate 500 MG [Erythrocin]
SBDC · 1720314 -
Erythromycin Injection [Erythrocin]
SBDF · 1720315 -
Erythromycin lactobionate Injection [Erythrocin]
SBDFP · 2656070 -
Erythrocin Injectable Product
SBDG · 1720316 -
Erythrocin
BN · 645943
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1668267 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-6482-01 | 10 VIAL in 1 TRAY (0409-6482-01) / 10 mL in 1 VIAL (0409-64... | Erythrocin Lactobionate | Hospira, Inc. | 2005-05-25 |
Observed labelers:
Hospira, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1364 | Erythro lactobionate /500 mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.